HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Glied, S Search for Related Content PubMed PubMed Citation Articles by Glied, S

Estimating the indirect cost of illness: an assessment of the forgone earnings approach.

S Glied

School of Public Health, Columbia University, New York, NY 10032, USA.

OBJECTIVES: This study attempted to assess (1) the accuracy of estimates of the indirect cost of illness and death computed with the human capital (forgone earnings) method and (2) the sensitivity of these estimates to key assumptions and parameters. METHODS: The study used data from the annual Current Population Surveys of 1964 through 1988 to compare the earnings experience of cohorts of White men aged 18 through 65 with predictions made with the human capital method. The study then assessed the sources and magnitude of the observed differences. RESULTS: Predictions of forgone earnings can be as much as 18% greater or 20% smaller than actual earnings, under identical assumptions, depending on the data used. While in most cases errors are quite small, alternative, equally plausible estimates of forgone earnings may differ by as much as 50%. Estimates differed mainly because of (1) the cross section chosen to make the predictions and (2) assumptions about future earnings growth. However, other factors, such as cohort size, also contributed to variation. CONCLUSIONS: Researchers and policymakers should be very careful in making and interpreting estimates of the indirect cost of illness and death.

This article has been cited by other articles:

				G. de Lima Lopes Jr and S. Gluck Health Economics in the Journal of Clinical Oncology and an Evaluation of the Indirect Costs and Benefits Associated With Adjuvant Trastuzumab J. Clin. Oncol., August 1, 2007; 25(22): 3382 - 3383. [Full Text] [PDF]

				F. L. Lynch, M. Hornbrook, G. N. Clarke, N. Perrin, M. R. Polen, E. O'Connor, and J. Dickerson Cost-effectiveness of an Intervention to Prevent Depression in At-Risk Teens Arch Gen Psychiatry, November 1, 2005; 62(11): 1241 - 1248. [Abstract] [Full Text] [PDF]

				C. P. Gross, G. F. Anderson, and N. R. Powe The Relation between Funding by the National Institutes of Health and the Burden of Disease N. Engl. J. Med., June 17, 1999; 340(24): 1881 - 1887. [Abstract] [Full Text] [PDF]